All I can say Hector, is keep your eye on the prize and don't listen to so much dribble. It's wasted energy.
If people really want to be informed, why don't they go to the Gilead website and really listen to what's going on. I think they would be pleasantly surprised. I personally cannot wait for the upcoming screening and if I'm lucky enough to be give one pill for the cure, I will thank my lucky stars.....for the rest of my life.
Blessings to you!
We are are treating with GS-7977 ourselves. We didn't ask others to hijack this thread for their own anti-capitalist anti-pharmaceutical 'theories'.
Some of us treated previously with peg-interferon and ribavirin. Some of us failed treatment with peg-interferon based treatment because we don't response to interferon. We have now have a non-interferon treatment that is working for us without all the side effects that the folks treating with triple therapy are experiencing. Why begrudge us our chance to treat and cure our hepatitis C???
In my case and the others in my clinical trial, hepatitis C has destroyed our livers and caused us to develop liver cancer for which the only cure is a transplant. We all have a need to get a transplant within the next 6 months before our cancer kills us. Knowing that during transplant hepatitis C universality reinfects the donor liver which can cause cirrhosis and liver failure in 5 years in 30% of hep C reinfected post transplant patients, why shouldn't we try to increase our longevity post transplant? I realize that the critics have no insight into what some of us have gone through living with decompensated cirrhosis and liver cancer, their ignorance is no excuse to rain on our hopes.
So for the critics the have nothing positive to say and know nothing about our treatment, please keep your ignorance and rants to yourselves. We didn't ask for your opinion. This forum is for people to share their experiences with treatment. We are trying to share our experiences among ourselves because we are treating or have treated with GS-7977. We have just as much right to do so as do the folks that are treating with triple therapy or have treated with triple therapy. This forum is not a place to promote utopian dreams and vent your hatred of capitalism or pharmaceutical companies. Please find the appropriate forum for that. I'm sure there of plenty of such places on the Internet. If you choose never to purchase any drug or never have any medical interventions that is your choice and you are free to practice what you preach. No one is forcing you to treat your hepatitis C or any other condition... although I don't know why you are on this forum because it is for persons interested in the appropriate treatment of hepatitis C and people struggle to over come hepatitis C using current treatment therapy's.
Hector
Hope you are right. No way I'd wager on it simply because we heard so much of the same type of talk with the triple tx. Even my hepatologist who goes to all the liver conventions said it would be approved a good two years or so before it was.
These things can drag on. Hope I'm wrong though and the new orals are available sooner than later.
My 9/11/12 post on another thread ("Clinical trial GS-7977 and BMS-790052" in which many posters were lambasting Gilead for not going forward with BM in testing all oral combo therapy) is relevant to this thread, so I have copied that prior post below.
I have a different take on what is optimal.
The course Gilead is taking was clearly articulated in its 7/26/12 earnings call (transcripts available online) and seems like a "grand slam homerun" approach to me. Gilead has gotten approval from the FDA for a Phase 3 study using GS-7977 and GS 5885 (like declatasvir, an NS5A inhibitor). Other parameters will be set after the results of a small confirmatory Phase III study are reviewed (around the end of this calendar year, it would appear). The time schedule is very aggressive -- if everything goes as planned, the fixed dose combination regulatory filings would be made in mid-2014 -- much faster than could be achieved if the study had to be coordinated between two different pharmaceutical companies, as would be the case if GS-7977 were paired with the Bristol Myers drug declatasvir rather than with the GS-5885.
Granted, there are some question marks (most notably whether GS 5885 will indeed prove to be the equivalent of declatasvir), but that will be known very soon. I'd put my money on the notion that the GS- 7977/5885 combo will be the silver bullet and that will be borne out with lightening speed.
BTB
Wow, you know I really feel that you are making assumptions and kind of investing your own spin on things because you are angry at them for not doing what seems like a no brainer and working with Bristol Meyers to bring a combo drug to market that any genotype can use. BUT Odin, we are talking literally about Gilead spending 11 billion dollars to acquire 7977 and millions upon millions of dollars to now do trials etc. to begin to get it to market. I really feel that we don't know what is happening. They are saying they are close to having something ready and maybe they don't need to partner with Bristol. Hey, I don't know and I am just a Hep C patient and that's it. No vested interest other than to hopefully get well. So, please, Odin, watch the clinical trials and get ready to sign up if you are still waiting for that cure. I truly believe it's coming. As for me, we'll see. I'm not breaking out the champagne quite yet. Why not e-mail that person I wrote about from Gilead to ask. She is the coordinator or something for the trials for 7977. I wish you the best so much.
Another thing the Big Companies do not realize is, if it wasn't for us THE PEOPLE that goes through these Trials, it's what's making it happen for ALL of Us..meaning Cure for All and $$ for the Companies and all research...
I myself, am on 1 of the GS7977 Phase 3 GT 1,4,5,6 Clinical Study.. Neutrino as I read in the Article above..Last week of tx started today..
Country~
I don't understand anyone saying it's put the cure back ten years! Gilead will be filing for FDA approval next year for 7977+riba for geno's 2 and 3 and look to hopefully follow that up in 2014 for geno 1's with 7977+5885.
What does one mean that they'll stop research? When you have the cure, you have the cure! Gilead have never stopped research with HIV. In fact they're the leading pharma in that department and I would say that the world should be very happy about that. Personally, I'm feeling very good about what they have to offer.